Coronary interventions
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions October 18, 2019 | 10.4244/EIJ-D-18-00292
Showing 1-20 of 42 articles
Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial
September 20, 2019 | 10.4244/EIJ-D-19-00324
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries
September 20, 2019 | 10.4244/EIJ-D-16-00796
Coronary interventions
Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study April 5, 2019 | 10.4244/EIJ-D-17-01087
Coronary interventions
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study December 7, 2018 | 10.4244/EIJ-D-18-00491
Coronary interventions
Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial December 7, 2018 | 10.4244/EIJ-D-18-00762
Coronary interventions
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) October 12, 2018 | 10.4244/EIJ-D-18-00301
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
March 20, 2018 | 10.4244/EIJ-D-17-00720
Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease
November 20, 2017 | 10.4244/EIJ-D-17-00328
Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”
October 11, 2017 | 10.4244/EIJ-D-17-00187
Coronary interventions
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III July 20, 2017 | 10.4244/EIJ-D-17-00254
Interventions for valvular disease
The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique May 15, 2017 | 10.4244/EIJ-D-16-00647
Coronary interventions
Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study April 7, 2017 | 10.4244/EIJ-D-16-00868
Coronary interventions
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial December 9, 2016 | 10.4244/EIJY15M10_04
Coronary interventions
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials November 20, 2016 | 10.4244/EIJV12I10A206
First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses
April 20, 2015 | 10.4244/EIJV10I12A242
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
April 20, 2015 | 10.4244/EIJV10I12A243